IgA Vasculitis Nephritis: A Case Series and Comparison of Treatment Guidelines

Table 1

IgAVN cases.

Patient	Age/race/gender	Organ involvement	Biopsy results	Therapy	Outcomes
1	22/C/M	Skin-abdomen-joints-kidney	<25% cellular crescents	GC, MMF	Improving proteinuria, in remission
2	55/C/M	Skin-kidney	Mesangial proliferation with IgA deposition	GC	Infection, death
3	42/C/M	Skin-kidney-abdomen	<25% cellular crescent	GC, CYC	Improving proteinuria, in remission
4	45/C/F	Skin-kidney-lung	MPGN with IgA-immune complex	GC, RTX	Infection, death
5	65/C/F	Skin-abdomen-kidney	<25% cellular crescents	GC, MMF	Improving proteinuria, stable creatinine

GC = glucocorticoids; MMF = mycophenolate mofetil; CYC = cyclophosphamide; RTX = rituximab; C = caucasian; F/M = female/male.